CoapTech Awarded $1.6 Million from NIH for PUMA System
Hunniwell's Series B Investment CoapTech was recently awarded $1.6 Million from NIH to finalize the development and trial of its Pediatric PUMA-G System.
The Rise of Miniature Robotics for Surgery
Hunniwell Lake Ventures Analyst explains how the recent wave of innovations in miniature surgical robotics is expanding their applications while improving quality and safety.
Meet the Founding Members of CoapTech
CoapTech Co-Founders CEO Howard Carolan and CMO Steve Tropello share their journey founding CoapTech and developing the novel PUMA system in order to relieve patient suffering and improve quality.
ViviMedia Interviews Richard Fang at F50 Global Capital Summit
HLV Founding Managing Partner Richard Fang shares his personal entrepreneurial experience, as well as the motivation and the differentiating strategies behind the Hunniwell Medical Device Fund.
Breakthroughs in Gastrointestinal Surgery
Hunniwell Lake Ventures shares key insights on the future of the rapidly growing Gastrointestinal medical device market.
WaveClear Raises $1.125 Million in Series A Funding Led by Hunniwell
WaveClear, Inc. announces the closing of a $1,125,000 Series-A round of investment led by Hunniwell Lake Ventures. They will use their funds to further develop the CaviClearTM Endovascular System, a minimally invasive and cost-effective ultrasound generated cavitation device for a broad range of endovascular applications.
CoapTech Raises $7M in Series B Funding Led by Hunniwell
CoapTech has closed a Series B investment of $7 million led by Hunniwell. The funds will be used to commercialize the First FDA-cleared, Ultrasound-based system for Feeding Tube Placement.
The Next Generation of Diagnostic Wearables
Rizlab Health is transforming the diagnostic device ecosystem with their rapid and portable hematology analyzer, Cytotracker, creates a method for highly accurate diagnostics for COVID-19 and beyond.
A New Wave of Dialysis Innovations
With the dangers of COVID-19, providers have pushed home dialysis as a safer option for ESRD patients. This has accelerated a new wave of dialysis innovations that offers ESRD patients a quality of life they've never fathomed having before.
Is Telehealth a Bubble?
Telehealth companies are seeing an exponential rise in their client base due to COVID-19. However, the rise of Internet-based healthcare comes with its own set of issues and potential concerns.
